Cargando…

Editorial: betaretrovirus in biliary epithelia of patients with autoimmune and cryptogenic liver disease – authors’ reply

Detalles Bibliográficos
Autores principales:	Wang, W, Indik, S, Wong, G K-S, Mason, A L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Invited Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329381/ https://www.ncbi.nlm.nih.gov/pubmed/25631652 http://dx.doi.org/10.1111/apt.13082

Ejemplares similares

Frequent proviral integration of the human betaretrovirus in biliary epithelium of patients with autoimmune and idiopathic liver disease
por: Wang, W, et al.
Publicado: (2015)

Characterization of a human betaretrovirus in patients with primary biliary cirrhosis
por: Wang, Weiwei, et al.
Publicado: (2014)

Linking Human Betaretrovirus with Autoimmunity and Liver Disease in Patients with Primary Biliary Cholangitis
por: Syed, Hussain, et al.
Publicado: (2022)

Isolation of a Human Betaretrovirus from Patients with Primary Biliary Cholangitis
por: Goubran, Mariam, et al.
Publicado: (2022)

Isolation of a human betaretrovirus resembling mouse mammary tumor virus (MMTV) from patients with primary biliary cirrhosis
por: Indik, Stan, et al.
Publicado: (2009)

Special Issue “Human Betaretrovirus and Related Diseases”
por: Mason, Andrew L.
Publicado: (2022)

Editorial: mesalazine to prevent recurrent acute diverticulitis—the final nail in the coffin. Authors’ reply
por: Kruis, W., et al.
Publicado: (2017)

Role of Novel Retroviruses in Chronic Liver Disease: Assessing the Link of Human Betaretrovirus with Primary Biliary Cirrhosis
por: Sharon, David, et al.
Publicado: (2015)

Editorial: increasing IBD prevalence and its complications in the context of the COVID‐19 pandemic. Authors' reply
por: King, Dominic Stephen, et al.
Publicado: (2020)

Editorial: gut microbial profile associated with primary sclerosing cholangitis—what is new and how do we progress from here? Authors’ reply
por: Rühlemann, Malte, et al.
Publicado: (2019)

Seroprevalence of Human Betaretrovirus Surface Protein Antibodies in Patients with Breast Cancer and Liver Disease
por: Zhang, Guangzhi, et al.
Publicado: (2020)

Corrigendum to “Seroprevalence of Human Betaretrovirus Surface Protein Antibodies in Patients with Breast Cancer and Liver Disease”
por: Zhang, Guangzhi, et al.
Publicado: (2020)

Betaretrovirus infections in dromedary camels in Saudi Arabia
por: Hemida, Maged Gomaa, et al.
Publicado: (2022)

Tight junctions in pulmonary epithelia during lung inflammation
por: Wittekindt, Oliver H.
Publicado: (2016)

A novel Betaretrovirus discovered in cattle with neurological disease and encephalitis
por: Hierweger, Melanie M., et al.
Publicado: (2021)

Detection and Characterisation of an Endogenous Betaretrovirus in Australian Wild Deer
por: Huaman, Jose L., et al.
Publicado: (2022)

Editorial: new insights into the relationship between the intestine and non‐alcoholic fatty liver—is “fatty gut” involved in disease progression?
por: Valenti, L., et al.
Publicado: (2017)

Researchers, authors and consent
por: Cornock, Marc
Publicado: (2022)

EDITORIAL
por: Ashworth, Peter
Publicado: (2010)

Correction to: A novel Betaretrovirus discovered in cattle with neurological disease and encephalitis
por: Hierweger, Melanie M., et al.
Publicado: (2022)

Identification of diverse full-length endogenous betaretroviruses in megabats and microbats
por: Hayward, Joshua A, et al.
Publicado: (2013)

AUTHOR REPLY TO EDITORIAL COMMENT
por: Shiff, Benjamin, et al.
Publicado: (2021)

The Role of a Betaretrovirus in Human Breast Cancer: Enveloping a Conundrum
por: Gunzburg, Walter H., et al.
Publicado: (2022)

Editorial: HBV—the naked truth?
por: Pasetto, Anna, et al.
Publicado: (2019)

Secondary bile acids and the biliary epithelia: The good and the bad
por: Lenci, Ilaria, et al.
Publicado: (2023)

Reply from Authors to the Editorial Comment
por: Kiss, Bernhard, et al.
Publicado: (2016)

Author’s Reply to Cryptogenic Stroke, Patent Foramen Ovale Closure, and Mid to Long-term Outcomes: Rising Shadows of Doubt
por: Lee, Oh-Hyun, et al.
Publicado: (2023)

Editorial: Rectal Urgency Among Patients with Ulcerative Colitis or Crohn’s Disease: Analyses from a Global Survey
por: Moon, Mackenzie, et al.
Publicado: (2023)

Reply to Hagen and Thornhill
por: Myers, Sarah, et al.
Publicado: (2017)

The authors’ reply re: The role of teleconsultation in the management of suspected skin malignancy in plastic surgery during COVID-19 outbreak: A single centre experience
por: Plonczak, Agata M, et al.
Publicado: (2022)

Author’s reply: Regarding the editorial by Penttinen and Friede
por: Penttinen, Pasi M, et al.
Publicado: (2016)

Current treatment of benign biliary strictures
por: Costamagna, Guido, et al.
Publicado: (2013)

Author’s Reply: HFE Gene Mutations (C282Y and H63D) in a Group of Patients With Cryptogenic Cirrhosis
por: Geramizadeh, Bita
Publicado: (2012)

Efferocytosis and autoimmune disease
por: Kawano, Mahiru, et al.
Publicado: (2018)

Atrial Fibrillation and Cryptogenic Thromboembolic Events
por: Henz, Benhur Davi, et al.
Publicado: (2018)

Recurrence of primary biliary cholangitis after liver transplantation: A Japanese perspective
por: Montano‐Loza, Aldo J., et al.
Publicado: (2017)

Advances in the endoscopic management of malignant biliary obstruction
por: Thomaidis, Thomas, et al.
Publicado: (2020)

Reply to Comment by Young et al.
por: Mathews, F., et al.
Publicado: (2009)

Editorial: serum HBV RNA biphasic decline in patients with HBeAg‐positive chronic hepatitis B treated with nucleos(t)ide analogues
por: Ding, Yang, et al.
Publicado: (2020)

Emperipolesis mediated by CD8(+) T cells correlates with biliary epithelia cell injury in primary biliary cholangitis
por: Zhao, Su‐xian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6guf7srs2pijfiffcld6kk5j0g